Pre-treatment haemoglobin concentration in accelerated and conventional radiotherapy for non-small cell lung carcinoma

Clinical Oncology

Volumn 16, Issue 1, 2004, Pages 58-62

  Sibtain, A ^a   Saunders, M I ^a   Bentzen, S M ^a   Hoskin, Peter J ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

CHART; Haemoglobin; Non small cell lung cancer; Radiotherapy

Indexed keywords

HEMOGLOBIN;

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; SURVIVAL TIME;

EID: 1042292049     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(03)00254-1     Document Type: Article

References (21)

1. Fein DA, Lee WR, Hanlon AL. Pretreatment hemoglobin level infuences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 1995;13:2077-2083.
2. Quilty PM, Kerr GR, Duncan W. Prognostic indices for bladder cancer: an analysis of patients with transitional cell carcinoma primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 1986;7:311-321.
3. Constantinou EC, Daly W, Fung CY. Time dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 1997; 39:651-657.
4. Evans JC, Bergsjo P. The influence of anaemia on the results of radiotherapy in carcinoma of the cervix. Radiology 1965; 84:709-717.
5. Jazieh AR, Hussain M, Howington JA, et al. Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer. Ann Thorac Surg 2000;70:1168-1171.
6. Ludwig H, Fritz E, Kotzmann H, et al. Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 1990; 322:1693-1699.
7. Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992;79:1987-1994.
8. Ludwig H, Fritz E. Anaemia in cancer patients. Semin Oncol 1996; 25(suppl 7):2-6.
9. Saunders M, Dische S, Barrett A, et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multi-centre trial. CHART Steering Committee. Lancet 1997; 350:161-165.
10. Saunders MI, Rojas A, Lyn BE, et al. Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer. Br J Cancer 1998;78:1323-1328.
11. Barrett-Lee PJ, Bailey NP, O'Brien ME, et al. Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. Br J Cancer 2000;82:93-97.
12. Spivak JL. Cancer related anaemia: its causes and characteristics. Semin Oncol 1996;21(suppl 3):3-8.
13. Nowrousan M. Pathophysiology of cancer related anaemia. In: Smyth J, ed. Rh Erythropoetinin cancer supportive treatment, 2nd edn. New York: Marcel Dekker, 1996.
14. Demetri GD, Kris M, Wade J, et al. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group. J Clin Oncol 1998; 16:3412-3425.
15. Gabrilove JL, Cleeland CS, Livingston RB, et al. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are sSimilar to three-times-weekly dosing. J Clin Oncol 2001; 19:2875-2882.
16. Dische S, Saunders MI, Warburton MF. Hemoglobin, radiation, morbidity and survival. Int J Radiat Oncol Biol Phys 1986; 12:1335-1337.
17. Wilhelm R, Kovacs G, Heinrichsohn D, et al. Survival of exclusively irradiated patients with NSCLC. Significance of pre-therapeutic hemoglobin level [in German]. Strahlenther Onkol 1998;174:128-132.
18. Oehler W, Fischer J, Merkle K. Does the initial hemoglobin value modify the primary tumor reaction? A study of 264 irradiated bronchial cancers [in German]. Radiobiol Radiother (Berl) 1990; 31:325-331.
19. Hong A, Dische S, Saunders MI, et al. Lung function and radiation response. Br J Radiol 1991;64:1134-1139.
20. Fyles AW, Milosevic M, Pintilie M, et al. Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiother Oncol 2000;57:13-19.
21. Jung C, Muller-Klieser W, Vaupel P. Tumor blood flow and O2 availability during hemodilution. Adv Exp Med Biol 1984; 180:281-291.